Alivus Life Sciences to hold virtual investor meeting
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, announced an upcoming investor/analyst meeting. This virtual one-on-one meeting, scheduled for December 18, 2025, will be held with Choice India.
The company stated that the schedule and mode of the meeting are subject to change due to exigencies from the investor/analyst or the company's side. Rudalf Corriea, company secretary and compliance officer of Alivus Life Sciences, made this disclosure to both BSE Ltd. and the National Stock Exchange of India Ltd.
The purpose of the meeting is to facilitate engagement between the company's representatives and the investor/analyst community. Alivus Life Sciences' corporate office is located in Mumbai, with its registered office in Solapur, India.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Glenmark Life Sciences publishes news
Free account required • Unsubscribe anytime